Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets

被引:42
作者
Miranda, Antonia [1 ]
Millan, Monica [1 ]
Caraballo, Isidoro [1 ]
机构
[1] Univ Seville, Fac Pharm, Dept Pharm & Pharmaceut Technol, E-41012 Seville, Spain
关键词
formulation; controlled release; solid dosage form; particle size; polymers;
D O I
10.1002/jps.20912
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In previous papers of our research group, a linear relationship between the drug percolation threshold and the relative drug particle size (drug/excipient) has been found, in the case of the inert matrices. The objective of the present paper is to investigate the influence of the particle size on the excipient percolation threshold in the case of hydrophilic matrices. This influence can have important consequences on the release behaviour of these controlled release devices. Matrix tablets have been prepared using KCI/Lobenzarit Disodium as drugs and HPMC K4M as matrix forming material, employing six different excipient/drug particle size ratios (ranging from 0.42 to 4.16). The formulations studied contain a drug loading in the range of 20-90% (w/w). In order to estimate the percolation threshold, the behaviour of the kinetic parameters with respect to the volumetric fraction of each component at time zero, was studied. The obtained results support the existence of a linear relationship between a component percolation threshold (drug or excipient) and its relative particle size (drug/excipient in the case of the drug percolation threshold or excipient/drug in the case of the excipient percolation threshold). This relationship is valid for different drugs, excipients and systems (inert or hydrophilic matrix tablets). (c) 2007 Wiley-Liss, Inc.
引用
收藏
页码:2746 / 2756
页数:11
相关论文
共 48 条
  • [1] ALDERMAN D A, 1984, International Journal of Pharmaceutical Technology and Product Manufacture, V5, P1
  • [2] [Anonymous], 1996, PHARM ACTA HELV, DOI [10.1016/S0031-6865(96)00023-4, DOI 10.1016/S0031-6865(96)00023-4]
  • [3] Modified drug release from inert matrix tablets prepared from formulations of identical composition but different organisations
    Barra, J
    Falson-Rieg, F
    Doelker, E
    [J]. JOURNAL OF CONTROLLED RELEASE, 2000, 65 (03) : 419 - 428
  • [4] Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate
    Bettini, R
    Catellani, PL
    Santi, P
    Massimo, G
    Peppas, NA
    Colombo, P
    [J]. JOURNAL OF CONTROLLED RELEASE, 2001, 70 (03) : 383 - 391
  • [5] BETTINI R, 1997, P 24 INT S CONTR REL, V24, P635
  • [6] BETTINI R, 1998, P 25 INT S CONTR REL, V24, P36
  • [7] BETTINI R, 1994, P INT S CONTROL RELE, V21, P19
  • [8] BONNY JD, 1991, PHARM ACTA HELV, V66, P160
  • [9] CAMPOSALDRETE ME, 1997, EUR J PHARM BIOPHARM, V43, P147
  • [10] PERCOLATION THEORY - APPLICATION TO THE STUDY OF THE RELEASE BEHAVIOR FROM INERT MATRIX SYSTEMS
    CARABALLO, I
    FERNANDEZAREVALO, M
    HOLGADO, MA
    RABASCO, AM
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 96 (1-3) : 175 - 181